506 related articles for article (PubMed ID: 12354724)
1. Tissue engineering of functional trileaflet heart valves from human marrow stromal cells.
Hoerstrup SP; Kadner A; Melnitchouk S; Trojan A; Eid K; Tracy J; Sodian R; Visjager JF; Kolb SA; Grunenfelder J; Zund G; Turina MI
Circulation; 2002 Sep; 106(12 Suppl 1):I143-50. PubMed ID: 12354724
[TBL] [Abstract][Full Text] [Related]
2. Tissue engineering of autologous human heart valves using cryopreserved vascular umbilical cord cells.
Sodian R; Lueders C; Kraemer L; Kuebler W; Shakibaei M; Reichart B; Daebritz S; Hetzer R
Ann Thorac Surg; 2006 Jun; 81(6):2207-16. PubMed ID: 16731156
[TBL] [Abstract][Full Text] [Related]
3. Human umbilical cord cells for cardiovascular tissue engineering: a comparative study.
Kadner A; Zund G; Maurus C; Breymann C; Yakarisik S; Kadner G; Turina M; Hoerstrup SP
Eur J Cardiothorac Surg; 2004 Apr; 25(4):635-41. PubMed ID: 15037283
[TBL] [Abstract][Full Text] [Related]
4. Prenatally fabricated autologous human living heart valves based on amniotic fluid derived progenitor cells as single cell source.
Schmidt D; Achermann J; Odermatt B; Breymann C; Mol A; Genoni M; Zund G; Hoerstrup SP
Circulation; 2007 Sep; 116(11 Suppl):I64-70. PubMed ID: 17846327
[TBL] [Abstract][Full Text] [Related]
5. Evolution of cell phenotype and extracellular matrix in tissue-engineered heart valves during in-vitro maturation and in-vivo remodeling.
Rabkin E; Hoerstrup SP; Aikawa M; Mayer JE; Schoen FJ
J Heart Valve Dis; 2002 May; 11(3):308-14; discussion 314. PubMed ID: 12056720
[TBL] [Abstract][Full Text] [Related]
6. Living autologous heart valves engineered from human prenatally harvested progenitors.
Schmidt D; Mol A; Breymann C; Achermann J; Odermatt B; Gössi M; Neuenschwander S; Prêtre R; Genoni M; Zund G; Hoerstrup SP
Circulation; 2006 Jul; 114(1 Suppl):I125-31. PubMed ID: 16820561
[TBL] [Abstract][Full Text] [Related]
7. The in vitro development of autologous fibrin-based tissue-engineered heart valves through optimised dynamic conditioning.
Flanagan TC; Cornelissen C; Koch S; Tschoeke B; Sachweh JS; Schmitz-Rode T; Jockenhoevel S
Biomaterials; 2007 Aug; 28(23):3388-97. PubMed ID: 17467792
[TBL] [Abstract][Full Text] [Related]
8. Minimally-invasive implantation of living tissue engineered heart valves: a comprehensive approach from autologous vascular cells to stem cells.
Schmidt D; Dijkman PE; Driessen-Mol A; Stenger R; Mariani C; Puolakka A; Rissanen M; Deichmann T; Odermatt B; Weber B; Emmert MY; Zund G; Baaijens FP; Hoerstrup SP
J Am Coll Cardiol; 2010 Aug; 56(6):510-20. PubMed ID: 20670763
[TBL] [Abstract][Full Text] [Related]
9. Comparative study of cellular and extracellular matrix composition of native and tissue engineered heart valves.
Schenke-Layland K; Riemann I; Opitz F; König K; Halbhuber KJ; Stock UA
Matrix Biol; 2004 May; 23(2):113-25. PubMed ID: 15246110
[TBL] [Abstract][Full Text] [Related]
10. The independent role of cyclic flexure in the early in vitro development of an engineered heart valve tissue.
Engelmayr GC; Rabkin E; Sutherland FW; Schoen FJ; Mayer JE; Sacks MS
Biomaterials; 2005 Jan; 26(2):175-87. PubMed ID: 15207464
[TBL] [Abstract][Full Text] [Related]
11. Construction of tissue-engineered heart valves by using decellularized scaffolds and endothelial progenitor cells.
Fang NT; Xie SZ; Wang SM; Gao HY; Wu CG; Pan LF
Chin Med J (Engl); 2007 Apr; 120(8):696-702. PubMed ID: 17517187
[TBL] [Abstract][Full Text] [Related]
12. Prenatally harvested cells for cardiovascular tissue engineering: fabrication of autologous implants prior to birth.
Weber B; Zeisberger SM; Hoerstrup SP
Placenta; 2011 Oct; 32 Suppl 4():S316-9. PubMed ID: 21575988
[TBL] [Abstract][Full Text] [Related]
13. Cyclic flexure and laminar flow synergistically accelerate mesenchymal stem cell-mediated engineered tissue formation: Implications for engineered heart valve tissues.
Engelmayr GC; Sales VL; Mayer JE; Sacks MS
Biomaterials; 2006 Dec; 27(36):6083-95. PubMed ID: 16930686
[TBL] [Abstract][Full Text] [Related]
14. The influence of heart valve leaflet matrix characteristics on the interaction between human mesenchymal stem cells and decellularized scaffolds.
Iop L; Renier V; Naso F; Piccoli M; Bonetti A; Gandaglia A; Pozzobon M; Paolin A; Ortolani F; Marchini M; Spina M; De Coppi P; Sartore S; Gerosa G
Biomaterials; 2009 Sep; 30(25):4104-16. PubMed ID: 19481252
[TBL] [Abstract][Full Text] [Related]
15. Cryopreserved amniotic fluid-derived cells: a lifelong autologous fetal stem cell source for heart valve tissue engineering.
Schmidt D; Achermann J; Odermatt B; Genoni M; Zund G; Hoerstrup SP
J Heart Valve Dis; 2008 Jul; 17(4):446-55; discussion 455. PubMed ID: 18751475
[TBL] [Abstract][Full Text] [Related]
16. In vivo remodeling and structural characterization of fibrin-based tissue-engineered heart valves in the adult sheep model.
Flanagan TC; Sachweh JS; Frese J; Schnöring H; Gronloh N; Koch S; Tolba RH; Schmitz-Rode T; Jockenhoevel S
Tissue Eng Part A; 2009 Oct; 15(10):2965-76. PubMed ID: 19320544
[TBL] [Abstract][Full Text] [Related]
17. In vitro fabrication of a tissue engineered human cardiovascular patch for future use in cardiovascular surgery.
Yang C; Sodian R; Fu P; Lüders C; Lemke T; Du J; Hübler M; Weng Y; Meyer R; Hetzer R
Ann Thorac Surg; 2006 Jan; 81(1):57-63. PubMed ID: 16368335
[TBL] [Abstract][Full Text] [Related]
18. Injectable living marrow stromal cell-based autologous tissue engineered heart valves: first experiences with a one-step intervention in primates.
Weber B; Scherman J; Emmert MY; Gruenenfelder J; Verbeek R; Bracher M; Black M; Kortsmit J; Franz T; Schoenauer R; Baumgartner L; Brokopp C; Agarkova I; Wolint P; Zund G; Falk V; Zilla P; Hoerstrup SP
Eur Heart J; 2011 Nov; 32(22):2830-40. PubMed ID: 21415068
[TBL] [Abstract][Full Text] [Related]
19. A new source for cardiovascular tissue engineering: human bone marrow stromal cells.
Kadner A; Hoerstrup SP; Zund G; Eid K; Maurus C; Melnitchouk S; Grunenfelder J; Turina MI
Eur J Cardiothorac Surg; 2002 Jun; 21(6):1055-60. PubMed ID: 12048086
[TBL] [Abstract][Full Text] [Related]
20. Living, autologous pulmonary artery conduits tissue engineered from human umbilical cord cells.
Hoerstrup SP; Kadner A; Breymann C; Maurus CF; Guenter CI; Sodian R; Visjager JF; Zund G; Turina MI
Ann Thorac Surg; 2002 Jul; 74(1):46-52; discussion 52. PubMed ID: 12118802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
